Overview
In Odisha’s Angul district, a 42‑year‑old woman named Malini married despite living with SCD. Her husband, Asish, a manager at MCL, could not overcome social stigma and the marriage did not happen. Their stories highlight the clash between medical screening and traditional marriage practices in a state where more than one‑tenth of the screened population carries the disease.
Key Developments
- Odisha records a 10.61% prevalence of sickle cell trait or disease among screened individuals, placing it among 17 high‑prevalence states.
- The Union launched the NSCAEP on 1 July 2023 across these states.
- A new voluntary forum, the NASCETC, held its first meeting on 26 September 2026 during the Odisha Haematology Association’s 16th annual congress.
- Experts stress that matching prenatal diagnosis and screening of partners is essential for safe marriages.
Important Facts
• Hydroxyurea, an approved drug, reduces pain episodes in SCD patients and is available in government hospitals. Hydroxyurea is part of the treatment protocol.
• Not every SCD patient needs a bone marrow transplant; most can lead normal lives with proper care.
• Social stigma often forces families to hide medication, avoid disclosing the condition during marriage negotiations, and seek treatment far from home, as observed in Kandhamal district.
Exam Relevance
The case illustrates the intersection of public health policy, social attitudes, and regional health disparities. Aspirants should link:
- GS‑III: Health – understanding genetic disorders, screening programmes, and drug availability.
- GS‑III: Social Justice – addressing stigma, community‑based interventions, and the role of NGOs like NASCETC.
- GS‑II: Governance – evaluating the design and implementation of NSCAEP and its monitoring mechanisms.
Way Forward
1. Strengthen community screening by integrating SCD tests into existing health‑check camps, especially in tribal and rural districts.
2. Expand awareness campaigns that replace horoscope matching with medical report matching, as advocated by experts.
3. Enhance counseling services to reduce stigma, involving local leaders, NGOs, and health workers.
4. Monitor NSCAEP outcomes through periodic surveys and publish findings to guide policy adjustments before the 2047 target.
5. Facilitate access to Hydroxyurea and train physicians in its optimal use, ensuring affordable supply in public hospitals.
By addressing both medical and social dimensions, India can move closer to eliminating SCD as a public health challenge.